Aureus Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $408K | Sell |
|
|||||
|
2022
Q4 | $609K | Hold |
|
|||||
|
2022
Q3 | $513K | Hold |
|
|||||
|
2022
Q2 | $374K | Hold |
|
|||||
|
2022
Q1 | $419K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $9.28M | Buy |
|
|||||
|
2016
Q2 | $7.43M | Buy |
|
|||||
|
2016
Q1 | $8.28M | Buy |
|
|||||
|
2015
Q4 | $6.27M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $4.17M | Sell |
|
|||||
|
2015
Q1 | $3.65M | Buy |
|
|||||
|
2014
Q4 | $3.38M | Hold |
|
|||||
|
2014
Q3 | $2.72M | Sell |
|
|||||
|
2014
Q2 | $5.36M | Buy |
|